Initial anticoagulation experience with standard-dose rivaroxaban after Watchman left atrial appendage occlusion.

Gu, Zhi-Chun; Qiao, Zhi-Qing; Hao, Zi-Yong; Li, Zheng; Jiang, Li-Sheng; Ge, Heng; He, Ben; Pu, Jun

Gu, Zhi-Chun; Qiao, Zhi-Qing; Hao, Zi-Yong; Li, Zheng; Jiang, Li-Sheng; Ge, Heng; He, Ben; Pu, Jun.

Afiliación

Gu ZC; Department of Pharmacy, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Qiao ZQ; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Hao ZY; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Li Z; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Jiang LS; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Ge H; Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
He B; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Pu J; Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.

Ann Transl Med ; 8(4): 105, 2020 Feb.

Article en En | MEDLINE | ID: mdl-32175398

Palabras clave

Left atrial appendage occlusion (LAAO); atrial fibrillation (AF); bleeding events; device-related thrombosis; rivaroxaban

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Transl Med Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google